NCT00003343View on ClinicalTrials.gov

Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

525

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

January 31, 2001

Conditions
Prostate Cancer
Interventions
DRUG

endocrine-modulating drug therapy

DRUG

mitoxantrone hydrochloride

DRUG

prednisone

DRUG

prinomastat

Trial Locations (1)

92037

Agouron Pharmaceuticals, Inc., La Jolla

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY